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Abstract
Background: Primary thyroid lymphomas (PTLs) account for 5% of thyroid malignant tumors and often develop in
patients with Hashimoto Thyroiditis (HT). Fine-needle cytology (FNC) is widely used in the diagnosis of thyroid
nodules, including those arising in HT. Two PTL cases in HT elderly patients are here described and discussed.
Methods: FNC was performed in rapidly enlarged thyroid nodules of 2 elderly patients under ultrasound (US)
control. FNC was used to prepare conventional cytologic smears, immunocytochemistry (ICC) and flow cytometry
(FC) assessment of cell populations.
Results: The above cases were diagnosed as well differentiated, small B-cell and diffuse large B-cell thyroid
lymphomas, respectively, by means of FNC. The histological diagnoses were mucosa-associated non Hodgkin
lymphoma (MALT) and diffuse large B-cell lymphoma (DLBCL), confirming FNC diagnoses, and patients were
treated accordingly.
Conclusions: FNC diagnosis of PTL is reliable and accurate; it may be conveniently used in the clinical practice
since it provides indications for appropriate therapeutic procedures or diagnostic surgery, and avoids to treat
benign nodules.
Introduction
Primary thyroid lymphomas (PTLs) are a rare group of
diseases that accounts for 5% of all thyroid malignant
tumors, and approximately for 1/2% of all extra nodal
lymphomas. Most PTLs are B- and T-cell non-Hodgkin
lymphomas (NHLs), whereas primary thyroid Hodgkin
lymphoma (HL) has been occasionally reported [1]. An
high percentage of PTLs affects patients suffering from
long standing Hashimoto Thyroiditis (HT), therefore
PTL pathogenesis is probably related to chronic inflam-
mation stimulation [2]. Although HT mainly affects
women and adult patients, men and younger patients
may also be affected [2-4]. PTL clinical signs include a
rapidly enlarging mass in the thyroid area, variable hoar-
seness and dyspnea. NHL symptoms, such as weight
loss, fever and nocturnal sweats, may also be present,
although less frequently. Most PTLs are B-cell NHL,
being mucosa-associated-lymphoid tissue (MALT) lym-
phoma and diffuse large B-cell lymphoma (DLBCL) the
most frequently reported histotypes [5]. Treatment and
prognosis depend on the specific subtype and staging;
surgical treatment of localized tumors, radio and che-
motherapy for low-grade and high-grade histotypes
respectively is generally utilized [6]. A 5-year survival of
90% has been reported in correctly diagnosed and trea-
ted PTL patients [7]; therefore a timely and accurate
diagnosis of PTL is mandatory for treatment and prog-
nosis. Palpable neck masses are not a rare occurrence,
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some time representing a challenging diagnostic
dilemma with unusual extrathyroidal masses [8,9]. Sero-
logical or cellular biomarkers would be of great diagnos-
tic utility to distinguish benign from malignant thyroid
nodules [10]. For instance, an increase in circulating
levels of pro-angiogenic cytokines, as well as of bone
marrow-derived endothelial progenitor cells (EPCs), has
been observed in tumor patients [11-14]. Unfortunately,
calcitonin is the only available biomarker to this pur-
pose, and its utility is limited to the diagnosis of medul-
lary thyroid carcinoma. Both molecular and functional
studies have revealed that neoplastic cells remodel their
Ca2+ signaling machinery [11,15-18], thereby leading the
notion that up-regulated plasmalemmal Ca2+-permeable
channels might serve as alternative diagnostic markers
of neoplastic transformation [18]. Unfortunately, these
studies are yet to be performed in PTL. Fine-needle
cytology (FNC) is the primary diagnostic tool [19-24]
for all other nodular thyroid diseases. Inconclusive
results are frequent and the application of molecular
techniques to FNC has dramatically increased its sensi-
tivity [24-32], including in HT cases with diffuse or nod-
ular enlargement [31]. These advantages are enhanced
in case of HT, which does not require surgical treat-
ment, and even more in elderly patients, for whom
surgery is generally more burdensome, complex and
expensive than younger patients [33]. The aim of this
study is to present 2 cases of PTL in elderly patients in
which FNC pre-surgical diagnosis has contributed to a
correct and differentiated treatment.
Materials and methods
Between January 2010 and December 2012, 1.256
patients with thyroid nodules or diffuse swelling under-
went FNC in the outpatient clinics of the Azienda Ospe-
daliera Universitaria, University of Salerno. Two of these
patients were diagnosed with PTL; the first patient was
a 66-year-old man who suffered from long standing HT.
The gland had progressively enlarged in the last months
causing dyspnea and difficulty in swallowing. The sec-
ond was a 68-year-old woman with an undefined history
of long standing goiter, who complained dyspnea, voice
change and choking. Both patients underwent ultra-
sound (US)-guided FNC with rapid on-site evaluation
(ROSE), as previously described [34-36]. The diagnostic
procedure and its related risks were first discussed with
the patients, who were also informed that 1 or 2 supple-
mentary passes might have been needed, and an
informed consent was obtained. Additional passes were
used to prepare additional smears for immunocyto-
chemistry (ICC) and cell suspensions in buffer solution
to perform flow cytometry (FC) assessment of the cell
populations. Monoclonal antibodies used for ICC were
directed against thyroglobulin (TG), leucocyte common
antigen (LCA), cytokeratin (CK), CD20, CD3, CD4,
CD8, CD5, CD10, CD19, kappa and lambda light chains.
Fluoresceinated antibodies for FC were: basic combina-
tions of phycoerythrin (PE), perdin chlorophyll protein
(PERCP) and fluorescein isothiocyanate (FITC) antibo-
dies. Antibodies were purchased from Becton Dickinson
(San José, CA). Antibodies clones, dilutions and techni-
cal details for both procedures were previously described
[37,38]. In particular, FC data were interpreted accord-
ingly in this specific clinical and anatomical setting
[32,39]; with regard to the light chain evaluation for clo-
nal assessment of the lymphoid cell populations, a per-
centage of the gated cells showing /l unbalance ≤ 20%
of the gated cells was considered evidence of clonality
[32]. FC and ICC assessments were used to perform the
final diagnoses and were included in the cytological
reports.
Results
Case 1: At the time of FNC, US evaluation showed dif-
fuse homogeneous enlargement of the right thyroid lobe,
that measured 60 mm in diameter. The edges were
smooth and the gland showed a homogeneous isoechoic
pattern; FNC showed a dispersed population of immature
medium size (Figure 1) lymphoid cells and small mature
lymphocytes intermingled among the main cell popula-
tion. Immature large lymphoid cells were roundish,
2 times the size of the mature lymphocyte and showed
granular chromatin, nuclear membrane irregularities and
1 or 2 evident nucleoli. No thyroid follicular cells were
observed. ICC showed LCA- and CD20-positivity in the
main large cell population, CD3-positivity in small lym-
phocytes, and negativity for thyroglobulin. FC assessment
of gated lymphocytes showed a large proportion of
B-lymphocytes, identified by CD19. T-lymphocytes,
identified by CD5, CD4 and CD8, were also present.
B-lymphocytes were CD10-negative and showed k light
chain restriction in 40% of the cell population (Figure 2).
The differential diagnosis between PTL and HT with
severe lymphoid infiltrate was taken into account. None-
theless, HT was excluded because it generally shows lym-
phoid cells of variable size, plasma cells and tingible body
macrophages, which were absent in this case. Moreover,
the above reported k-light chain restriction was consid-
ered diagnostic for a B-cell type PTL arisen in HT. The
patient received combination chemotherapy (CHOP) with
local radiotherapy without surgical treatment; he is alive
and free from signs of disease, to date.
Case 2: US showed an ill-defined, hypoechoic mass
that, starting from the left thyroid lobe, infiltrated the
surrounding neck structures including the sternocleido-
mastoid muscle. FNC showed an immature and dis-
persed large cell population. Cells showed evident
nuclear abnormalities, coarse chromatin and 1 or
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2 evident nucleoli (Figure 3). Scattered mature lympho-
cytes were present in the background, and no thyroid
follicular cells were observed. ICC showed positivity for
LCA, CD20 and for CD3 in small lymphocytes, being
the main large cell population, and negativity for thyro-
globulin. FC assessment of gated lymphocytes showed
the large cells to be B-lymphocytes, identified by CD19.
T-lymphocytes, identified by CD5, CD4 and CD8, were
also present. B-lymphocytes were CD10-negative; light
chains were not expressed. Because of the clinical presen-
tation and the cytological features, a differential diagnosis
of a possible anaplastic carcinoma was pointed out. None-
theless, this possibility was excluded as ICC and FC data
assessed the lymphoid B-cell origin of the neoplastic cells
and FC did not detect light chain restriction. Therefore a
cytological diagnosis of large B-cell NHL was pointed out.
Notwithstanding the US and clinical presentation, lobect-
omy was performed and the following histopathological
analysis confirmed the cytological diagnosis of NHL,
which was morphologically and immunohistochemically
consistent with diffuse large B-cell non-Hodgkin lym-
phoma (Figure 4). The patient received combination che-
motherapy (CHOP) with local radiotherapy; she is alive
and residual disease was detected at the last follow-up.
Discussion
Primary thyroid lymphoma (PTL) is a lymphomatous
process which develops in the thyroid without involve-
ment of primary lymphoid organs or distant metastases
at diagnosis [40]. As reported above, PTL mostly arises
in the setting of autoimmune thyroiditis and takes an
average of 20 to 30 years to develop after the onset of
lymphocytic thyroiditis [41]. PTL frequently presents in
IE/IIE clinical stages, with some clinical and imaging
problems. A short history of a rapidly enlarging neck
mass, often associated with dyspnea, difficulty in swal-
lowing, or voice change, is the hallmark presentation of
thyroid lymphoma [42]. These signs, as well as imaging
procedures, may overlap with those of other benign and
Figure 1 Case 1 FNC smear showing monomorphic population of atypical lymphoid cells. Thyroid follicular cells are absent. (Diff Quik
stain 430X).
Figure 2 Flow cytometry diagram showing Ä¸ light chain
restriction.
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malignant thyroid pathologies and require an accurate
pre-surgical diagnosis. FNC is the most frequently used
procedure for the initial pathological diagnosis of thyr-
oid nodules [43]. Conventional examination of cytologic
smears yields inconclusive results that can be refined by
testing for specific genetic alterations [26,27,44,45]. FNC
has the highest levels of sensitivity and specificity [43],
but studies have shown inconsistent results in the diag-
nosis of PTL. A correct diagnosis of PTL with FNC was
made in 70/80% of cases [46], whereas other studies
report that FNC was suggestive but not diagnostic in
only 50/60% of cases [47,48]. The 2 study cases were
both correctly diagnosed and are an example of the
2 main occurring histotypes, the cytological diagnostic
difficulties and the importance of ancillary techniques
applied to FNC. As reported above, in the first case the
main differential diagnosis of HT with severe lymphoid
infiltrate was pointed out. Indeed, the US presentation
of HT is quite variable, ranging from normal thyroid
parenchyma imaging to diffuse homogeneus enlarge-
ment or atrophy, up to uninodular or multinodular pre-
sentation in +/-50% of cases [49,50]. The US appearance
of the nodules is also extremely variable; nodules may
be hypo or hyper echoic, can have calcifications (micro
and scattered, macro or eggshell calcifications), and may
also show a hypoechoic halo. The cytological presenta-
tion showed the prevalence of lymphoid cells, which
gave smears a lymph node-like appearance, including
the prevalence of immature follicular centre cells.
Finally, the possible presence of small clones of B cells
with light chain restriction has been reported in HT,
adding further diagnostic difficulties. On the other side,
the monotonous cytological smear of immature lym-
phoid cells, the lack of thyroid follicular cells and the
presence of large chain restrictions in most FC assess-
ments of T gated cells strongly supported the diagnosis
of PTL. In the second case, other diagnostic difficulties
were encountered; in fact, clinical presentation and cyto-
logical features clearly indicated a malignant tumor, but
a differential diagnosis of possible anaplastic carcinoma
was pointed out. However, in this case FC did not show
light chain expression, as it can occur in high grade
B-cell NHL. Nonetheless, ICC and FC clearly indicated
Figure 3 Case 2 FNC smear showing atypical large lymphoid cells in a necrotic background (Diff Quik stain 430X).
Figure 4 Histological section of case 2 showing atypical
lymphoid cells infiltrating the muscle (Hematoxylin-Eosin
430X).
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the lymphoid B-cell origin of the neoplastic cell. There-
fore properly used ancillary techniques, together with
clinical and imaging data and cytological features,
allowed the diagnosis of PTL. This possibility enhances
the cytological diagnosis not only in PTL cases, but also
in the benign hyperplastic and nodular presentation of
HT, in which surgery should not be considered neither
for diagnostic or therapeutic purposes. PTL treatment is
similar to other nodal NHLs. In case of intermediate or
high-grade lymphoma, the best results are obtained with
cyclophosphamide, doxorubicin, vincristine and predni-
solone (CHOP) based chemotherapy. Radiotherapy is
generally used after 3-6 CHOP courses in the form of
modified mantle irradiation, including thyroid, bilateral
neck, supraclavicular area and mediastinum [4]. Unfavor-
able prognostic factors include age (> 60 years), elevated
levels of serum lactate dehydrogenase (LDH) and b2
microglobulin, extranodal sites involvement and III-IV
stage [46]. Our patients received CHOP-based che-
motherapy and radiotherapy; both are alive with (case 2)
and without (case 1) signs of disease. In conclusion, the
cytological diagnosis of PTL is reliable and accurate;
it may be conveniently used in the clinical setting since it
provides indications for diagnostic surgery, when needed,
and avoids to treat HT cases.
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